Non-melanoma skin cancer: Occupational risk from UV light and arsenic exposure

Reviews on Environmental Health

Volumn 29, Issue 3, 2014, Pages 255-264

  Surdu, Simona ^a  

^a UNIVERSITY AT ALBANY   (United States)

Author keywords

arsenic; non melanoma skin cancer; occupational exposure; sunlight; ultraviolet light

Indexed keywords

ARSENIC;

CHEMICALLY INDUCED; HUMAN; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RISK FACTOR; SKIN NEOPLASMS; TOXICITY;

ARSENIC; HUMANS; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RISK FACTORS; SKIN NEOPLASMS;

EID: 84908101570     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh-2014-0040     Document Type: Article

References (87)

1. IARC. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42, Supplement 7. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 1987.
2. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, et al. Listing occupational carcinogens. Environ Health Perspect 2004; 112: 1447-59.
3. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26: 1657-67.
4. Franceschi S, Levi F, Randimbison L, La Vecchia C. Site distribution of different types of skin cancer: New aetiological clues. Int J Cancer 1996; 67: 24-8.
5. Epstein JH. Nonmelanoma skin cancer. Compr Ther 1996; 22: 179-82.
6. Gallagher RP, Bajdik CD, Fincham S, Hill GB, Keefe AR, et al. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 1996; 5: 419-24.
7. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002; 147: 41-7.
8. EPA. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. Washington, DC: US Environmental Protection Agency, 1988.
9. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995a; 131: 164-9.
10. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995b; 131: 157-63.
11. Couve-Privat S, Bouadjar B, Avril MF, Sarasin A, Daya-Grosjean L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002; 62: 7186-9.
12. Karagas MR, Cushing GL, Jr., Greenberg ER, Mott LA, Spencer SK, et al. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001; 85: 683-6.
13. Gasparro FP. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence. Am J Clin Dermatol 2000; 1: 337-48.
14. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: Review and update on epidemiologic correlations. Skinmed 2004; 3: 132-9.
15. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001; 63: 8-18.
16. Saraiya M, Glanz K, Briss PA, Nichols P, White C, et al. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. Am J Prev Med 2004; 27: 422-66.
17. Young AR. Tanning devices-fast track to skin cancer? Pigment Cell Res 2004; 17: 2-9.
18. IARC. Solar and ultraviolet radiation. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 1992.
19. IARC. Exposure to artificial UV radiation and skin cancer. Lyon, France: International Agency for Research on Cancer, World Health Organization, 2006.
20. IARC. A review of human carcinogens: Radiation. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 2012.
21. ATSDR. Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Public Health Service, 2007.
22. Mitropoulos P, Norman R. Occupational nonsolar risk factors of squamous cell carcinoma of the skin: a population-based casecontrolled study. Dermatol Online J 2005; 11: 5.
23. Peate W. Occupational skin disease. Am Fam Physician 2002; 66: 1025-32.
24. Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E. Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies. Radiology 2004; 233: 313-21.
25. WHO. INTERSUN, the global UV project: a guide and compendium. Geneva, Switzerland: World Health Organization, 2003a.
26. Lucas R, McMichael T, Smith W, Armstrong B. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation. Geneva, Switzerland: World Health Organization, 2006.
27. WHO. Ultraviolet radiation as a hazard in the workplace. Geneva, Switzerland: World Health Organization, 2003b.
28. Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation exposure among outdoor workers: State of the evidence and recommendations. Environ Health [serial on the Internet]. 2007; 6. Available from: http://www.ehjournal.net/content/6/1/22.
29. NIOSH. Criteria for a recommended standard: occupational exposure to ultraviolet radiation. Cincinnati, Ohio: National Institute for Occupational Safety and Health, 1972.
30. Suárez B, López-Abente G, Martínez C, Navarro C, Tormo M, et al. Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study. BMC Public Health 2007; 7: 180.
31. WHO. Arsenic in drinking-water. Background document for development of WHO guidelines for drinking-water quality. Geneva, Switzerland: World Health Organization, 2011.
32. EPA. Arsenic, inorganic (CASRN 7440-38-2): carcinogenicity assessment for lifetime exposure. Washington, DC: Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, 1998a.
33. Nordstrom DK. Worldwide occurrences of arsenic in ground water. Science 2002; 296: 2143-5.
34. NRC. Arsenic in drinking water. 2001 Update. Washington, DC: U.S. National Research Council, National Academy Press, 2001.
35. WHO. Air quality guidelines, 2nd ed. Arsenic. Copenhagen, Denmark: World Health Organization Regional Office for Europe, 2000.
36. WHO. Arsenic and arsenic compounds, 2nd ed. Geneva, Switzerland: Environmental Health Criteria 224, International Programme on Chemical Safety, World Health Organization, 2001.
37. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicology Lett 2002; 133: 1-16.
38. Hughes MF. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 2006; 114: 1790-6.
39. Pellizzari ED, Clayton CA. Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS). Environ Health Perspect 2006; 114: 220-7.
40. Tchounwou PB, Patlolla AK, Centeno JA. Invited reviews: carcinogenic and systemic health effects associated with arsenic exposure - a critical review. Toxicol Pathol 2003; 31: 575-88.
41. Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 2006; 114: 1193-8.
42. Chan CP, Huff J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcino & Ecotox Revs 1997; C15: 83-122.
43. EPA. Health assessment document for inorganic arsenic. Research Triangle Park, NC: U.S. Environmental Protection Agency, 1984.
44. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008; 21: 28-44.
45. EPA. Locating and estimating air emissions from sources of arsenic and arsenic compounds. Research Triangle Park, NC: U.S. Environmental Protection Agency, 1998b.
46. EPA. Carcinogenicity assessment for lifetime exposure to arsenic. Cincinnati, OH: U.S. Environmental Protection Agency, 1994.
47. WHO. Guidelines for drinking water quality. Recommendations, 3rd ed. Geneva, Switzerland: World Health Organization, 2006.
48. WHO. Guidelines for drinking water quality. Recommendations, 2nd ed. Geneva, Switzerland: World Health Organization, 1998.
49. Bauer A, Diepgen TL, Schmitt J. Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol 2011; 165: 612-25.
50. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour study group. Am J Epidemiol 1996; 144: 1034-40.
51. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46: 356-61.
52. Kricker A, Armstrong BK, English DR, Heenan PJ. A doseresponse curve for sun exposure and basal cell carcinoma. Int J Cancer 1995; 60: 482-8.
53. Lichte V, Dennenmoser B, Dietz K, Hafner HM, Schlagenhauff B, et al. Professional risk for skin cancer development in male mountain guides - a cross-sectional study. J Eur Acad Dermatol Venereol 2010; 24: 797-804.
54. Kenborg L, Jorgensen AD, Budtz-Jorgensen E, Knudsen LE, Hansen J. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a populationbased case-control study. Cancer Causes Control 2010; 21: 1347-55.
55. Lock-Andersen J, Drzewiecki KT, Wulf HC. The measurement of constitutive and facultative skin pigmentation and estimation of sun exposure in Caucasians with basal cell carcinoma and cutaneous malignant melanoma. Br J Dermatol 1998; 139: 610-7.
56. Milan T, Verkasalo PK, Kaprio J, Koskenvuo M. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 2003; 149: 115-23.
57. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135: 781-6.
58. Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho- Garnier H, et al. The multicentre south European study 'Helios'. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1447-54.
59. Seidler A, Husmann G, Nubling M, Hammer GP, Schmidtmann I, Blettner M, et al. UV-exponierte berufe und hauttumoren: berufsbezogene auswertung von daten des krebsregisters Rheinland-Pfalz. Zbl Arbeitsmed 2006; 56: 78-90.
60. Radespiel-Troger M, Meyer M, Pfahlberg A, Lausen B, Uter W, et al. Outdoor work and skin cancer incidence: a registry-based study in Bavaria. Int Arch Occup Environ Health 2009; 82: 357-63.
61. Walther U, Kron M, Sander S, Sebastian G, Sander R, et al. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004; 151: 170-8.
62. Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, et al. Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European study. PLoS ONE 2013a; 8: e62359.
63. Tobia L, Fanelli C, Bianchi S, Paglione M, Diana S, et al. [Professional exposure to natural ultraviolet radiation: risk assessment and management and preventing strategies]. G Ital Med Lav Ergon 2007; 29: 422-4.
64. Pelucchi C, Di Landro A, Naldi L, La Vecchia C. Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol 2007; 127: 935-44.
65. Gafa L, Filippazzo MG, Tumino R, Dardanoni G, Lanzarone F, et al. Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control 1991; 2: 395-9.
66. Corona R, Dogliotti E, D'Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001; 137: 1162-8.
67. Rosso S, Joris F, Zanetti R. Risk of basal and squamous cell carcinomas of the skin in Sion, Switzerland: a case-control study. Tumori 1999; 85: 435-42.
68. Lear JT, Tan BB, Smith AG, Bowers W, Jones PW, et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997; 90: 371-4.
69. Vlajinac HD, Adanja BJ, Lazar ZF, Bogavac AN, Bjekic MD, et al. Risk factors for basal cell carcinoma. Acta Oncol 2000; 39: 611-6.
70. Zanetti R, Rosso S, Martinez C, Nieto A, Miranda A, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-control study. Br J Cancer 2006; 94: 743-51.
71. Maia M, Proenca NG, de Moraes JC. Risk factors for basal cell carcinoma: a case-control study. Rev Saude Publica 1995; 29: 27-37.
72. Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, et al. Occupation and keratinocyte cancer risk: a populationbased case-control study. Cancer Causes Control 2007; 18: 895-908.
73. Hogan DJ, To T, Gran L, Wong D, Lane PR. Risk factors for basal cell carcinoma. Int J Dermatol 1989; 28: 591-4.
74. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 1989; 150: 475-8.
75. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-5.
76. Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 2011; 164: 291-307.
77. Pukkala E, Saarni H. Cancer incidence among Finnish seafarers, 1967-92. Cancer Causes Control 1996; 7: 231-9.
78. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003; 139: 890-4.
79. Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, Zanetti R, Rosso S, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer 2003; 88: 1702-7.
80. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001; 12: 552-7.
81. Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin. a case-control study in the Montreal region. Cancer 1985; 55: 907-11.
82. Hogan DJ, Lane PR, Gran L, Wong D. Risk factors for squamous cell carcinoma of the skin in Saskatchewan, Canada. J Dermatol Sci 1990; 1: 97-101.
83. Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, et al. Occupational exposure to arsenic and risk of non-melanoma skin cancer in a multinational European study. Int J Cancer 2013b; 133: 2182-91.
84. Gallagher RP, Lee TK. Adverse effects of ultraviolet radiation: a brief review. Prog Biophys Mol Biol 2006; 92: 119-31.
85. Kütting B, Drexler H. UV-induced skin cancer at workplace and evidence-based prevention. Int Arch Occup Environ Health 2010; 83: 843-54.
86. Smedley PL, Kinniburgh DG. A review of the source, behaviour and distribution of arsenic in natural waters. Applied Geochemistry 2002; 17: 517-68.
87. Gawkrodger DJ. Occupational skin cancers. Occup Med (Lond) 2004; 54: 458-63.